Neuroone Medical Technologies (NMTC) Accounts Payables (2014 - 2026)

Neuroone Medical Technologies (NMTC) has reported Accounts Payables for 13 consecutive years, with $905716.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables rose 93.64% year-over-year to $905716.0; the trailing twelve-month figure through Jun 2026 stood at $905716.0 (up 93.64% YoY), and the FY2025 full-year result was $1.0 million, down 1.83% from the prior year.
• Accounts Payables slipped to $905716.0 in Q2 2026 per NMTC's latest filing, from $934196.0 in the prior quarter.
• Across five years, Accounts Payables topped out at $1.0 million in Q3 2024 and bottomed at $325027.0 in Q2 2022.
• Historically, Accounts Payables has averaged $778480.2 across 5 years, with a median of $821238.5 in 2022.
• The sharpest annual moves came in 2023 and 2025: Accounts Payables surged 194.99% in 2023, then slumped 38.4% in 2025.
• Over 5 years, Accounts Payables stood at $861638.0 in 2022, then slipped by 11.8% to $760000.0 in 2023, then retreated by 2.04% to $744525.0 in 2024, then retreated by 25.81% to $552332.0 in 2025, then soared by 63.98% to $905716.0 in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $905716.0, $934196.0, and $552332.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.